Santa Cruz Biotechnology provides a broad selection of RT1-A monoclonal antibodies for advanced research in immunology and cellular biology. RT1-A monoclonal antibodies demonstrate high effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RT1-A is a critical component of the major histocompatibility complex (MHC) class I molecules in rats, playing a vital role in the immune response by presenting peptide antigens to CD8+ T cells. RT1-A molecules are essential for the recognition of self and non-self antigens, influencing the activation and regulation of immune responses. Understanding RT1-A function provides valuable insights into transplant biology, autoimmune diseases, and cancer immunology. Researchers can utilize RT1-A monoclonal antibodies to explore cellular mechanisms and molecular pathways involved in immune system regulation. RT1-A research continues to reveal new aspects of immune system function and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing immunological discoveries.